First steps towards a vaccine against Acinetobacter baumannii

Current Pharmaceutical Biotechnology

Volumn 14, Issue 10, 2013, Pages 897-902

  García Quintanilla, Meritxell ^a   Pulido, Marina R ^a   McConnell, Michael J ^a  

^a CSIC   (Spain)

Author keywords

Acinetobacter baumannii; Passive immunization; Vaccine

Indexed keywords

BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN A;

ACINETOBACTER INFECTION; ACTIVE IMMUNIZATION; ANTIBIOTIC THERAPY; APOPTOSIS; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; DOWN REGULATION; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; MORBIDITY; MORTALITY; NONHUMAN; PASSIVE IMMUNIZATION; PERITONITIS; REVIEW; UPREGULATION; VACCINE PRODUCTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BETA-GLUCANS; DRUG DISCOVERY; HUMANS;

EID: 84896699937     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201014666131226123511     Document Type: Review

References (40)

1. McConnell, M.J.; Actis, L.; Pachón, J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev., 2013, 37(2), 130-155.
2. Dijkshoorn, L.; Nemec, A.; Seifert, H. An increasing threat in hospitals: Multidrug-resistant acinetobacter baumannii. Nat. Rev. Microbiol., 2007, 5(12), 939-951.
3. European Centers for Disease Control and Prevention. ECDC, 2013.
4. Biswas, S.; Brunel, J.M.; Dubus, J.C.; Reynaud-Gaubert, M.; Rolain, J.M. Colistin: An update on the antibiotic of the 21st century. Expert. Rev. Anti Infect. Ther., 2012, 10(8), 917-934.
5. Adams, M.D.; Nickel, G.C.; Bajaksouzian, S.; Lavender, H.; Murthy, A.R.; Jacobs, M.R.; Bonomo, R.A. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother., 2009, 53(9), 3628-3634.
6. López-Rojas, R.; Jiménez-Mejias, M.E.; Lepe, J.A.; Pachón, J. acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: A case report from Spain. J. Infect. Dis., 2011, 204(7), 1147-1148.
7. Rolain, J. M.; Roch, A.; Castanier, M.; Papazian, L.; Raoult, D. Acinetobacter baumannii resistant to colistin with impaired virulence: A case report from France. J. Infect. Dis., 2011, 204(7), 1146-1147.
8. Taccone, F.S.; Rodríguez-Villalobos, H.; De Backer, D.; De Moor, V.; Deviere, J.; Vincent, J.L.; Jacobs, F. Successful treatment of septic shock due to pan-resistant acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur. J. Clin. Microbiol. Infect. Dis., 2006, 25(4), 257-260.
9. Valencia, R.; Arroyo, L.A.; Conde, M.; Aldana, J.M.; Torres, M.J.; Fernandez-Cuenca, F.; Garnacho-Montero, J.; Cisneros, J.M.; Ortiz, C.; Pachón, J.; Aznar, J. Nosocomial outbreak of infection with pan-drug-resistant acinetobacter. Baumannii in a tertiary care university hospital. Infect. Control Hosp. Epidemiol., 2009, 30(3), 257-263.
10. García-Quintanilla, M.; Pulido, M.R.; López-Rojas, R.; Pachón, J.; McConnell, M.J. Emerging therapies for multidrug resistant acinetobacter baumannii. Trends Microbiol., 2013, 21(3), 157-163.
11. Smith, S.G.; Mahon, V.; Lambert, M.A.; Fagan, R.P. A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol. Lett., 2007, 273(1), 1-11.
12. Choi, C.H.; Lee, E.Y.; Lee, Y.C.; Park, T.I.; Kim, H.J.; Hyun, S.H.; Kim, S.A.; Lee, S.K.; Lee, J.C. Outer membrane protein 38 of acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol., 2005, 7(8), 1127-1138.
13. Choi, C.H.; Lee, J.S.; Lee, Y.C.; Park, T.I.; Lee, J.C. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol., 2008, 8, 216.
14. Clemmer, K.M.; Bonomo, R.A.; Rather, P.N. Genetic analysis of surface motility in acinetobacter baumannii. Microbiology, 2011, 157(Pt 9), 2534-2544.
15. Luo, G.; Lin, L.; Ibrahim, A.S.; Baquir, B.; Pantapalangkoor, P.; Bonomo, R.A.; Doi, Y.; Adams, M.D.; Russo, T.A.; Spellberg, B. Active and passive immunization protects against lethal, extreme drug resistant-acinetobacter baumannii infection. Plos one, 2012, 7(1), e29446.
16. Loehfelm, T.W.; Luke, N.R.; Campagnari, A.A. Identification and characterization of an acinetobacter baumannii biofilm-associated protein. J. Bacteriol., 2008, 190(1), 1036-1044.
17. Fattahian, Y.; Rasooli, I.; Mousavi Gargari, S. L.; Rahbar, M. R.; Darvish Alipour Astaneh, S.; Amani, J. Protection against acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (bap). Microb. Pathog., 2011, 51(6), 402-406.
18. Rodríguez-Baño, J.; Martí, S.; Soto, S.; Fernández-Cuenca, F.; Cisneros, J.M.; Pachón, J.; Pascual, A.; Martínez-Martínez, L.; McQueary, C.; Actis, L.A.; Vila, J. Biofilm formation in acinetobacter baumannii: Associated features and clinical implications. Clin. Microbiol. Infect., 2008, 14(3), 276-278.
19. Bentancor, L.V.; Camacho-Peiro, A.; Bozkurt-Guzel, C.; Pier, G.B.; Maira-Litran, T. Identification of Ata, a multifunctional trimeric autotransporter of acinetobacter baumannii. J. Bacteriol., 2012, 194(15), 3950-3960.
20. Bentancor, L.V.; Routray, A.; Bozkurt-Guzel, C.; Camacho-Peiro, A.; Pier, G.B.; Maira-Litran, T. Evaluation of the trimeric autotransporter ata as a vaccine candidate against acinetobacter baumannii infections. Infect. Immun., 2012, 80(10), 3381-3388.
21. Maira-Litran, T.; Kropec, A.; Goldmann, D.; Pier, G.B. Biologic properties and vaccine potential of the staphylococcal poly-Nacetyl glucosamine surface polysaccharide. Vaccine, 2004, 22(7), 872-879.
22. Whitney, J.C.; Howell, P.L. Synthase-dependent exopolysaccharide secretion in Gram-negative bacteria. Trends Microbiol., 2013, 21(2), 63-72.
23. Choi, A.H.; Slamti, L.; Avci, F.Y.; Pier, G.B.; Maira-Litran, T. The pgaabcd locus of acinetobacter baumannii encodes the production of poly-beta-1-6-n-acetylglucosamine, which is critical for biofilm formation. J Bacteriol., 2009, 191(19), 5953-5963.
24. Bentancor, L.V.; O'Malley, J.M.; Bozkurt-Guzel, C.; Pier, G.B.; Maira-Litran, T. Poly-N-acetyl-beta-(1-6)-glucosamine is a target for protective immunity against acinetobacter baumannii infections. Infect. Immun., 2012, 80(2), 651-656.
25. Cywes-Bentley, C.; Skurnik, D.; Zaidi, T.; Roux, D.; Deoliveira, R.B.; Garrett, W.S.; Lu, X.; O'Malley, J.; Kinzel, K.; Rey, A.; Perrin, C.; Fichorova, R.N.; Kayatani, A.K.; Maira-Litran, T.; Gening, M.L.; Tsvetkov, Y.E.; Nifantiev, N.E.; Bakaletz, L.O.; Pelton, S.I.; Golenbock, D.T.; Pier, G.B. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc. Natl. Acad. Sci. USA, 2013, 110(24), E2209-E2218.
26. Maira-Litran, T.; Bentancor, L.V.; Bozkurt-Guzel, C.; O'Malley, J.M.; Cywes-Bentley, C.; Pier, G.B. Synthesis and evaluation of a conjugate vaccine composed of staphylococcus aureus poly-nacetyl- glucosamine and clumping factor A. Plos one, 2012, 7(9), e43813.
27. Russo, T.A.; Luke, N.R.; Beanan, J.M.; Olson, R.; Sauberan, S.L.; MacDonald, U.; Schultz, L.W.; Umland, T.C.; Campagnari, A.A. The K1 capsular polysaccharide of acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun., 2011, 78(9), 3993-4000.
28. Fedson, D. S.; Nicolas-Spony, L.; Klemets, P.; van der Linden, M.; Marques, A.; Salleras, L.; Samson, S.I. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev. Vaccines, 2011, 10(8), 1143-1167.
29. O'Loughlin, R.E.; Edmond, K.; Mangtani, P.; Cohen, A.L.; Shetty, S.; Hajjeh, R.; Mulholland, K. Methodology and measurement of the effectiveness of haemophilus influenzae type b vaccine: Systematic review. Vaccine, 28 (38), 6128-6136.
30. Safadi, M.A.; McIntosh, E.D. Epidemiology and prevention of meningococcal disease: A critical appraisal of vaccine policies. Expert Rev. Vaccines, 2012, 10(12), 1717-30.
31. Russo, T.A.; Beanan, J.M.; Olson, R.; MacDonald, U.; Cox, A.D.; St Michael, F.; Vinogradov, E.V.; Spellberg, B.; Luke-Marshall, N.R.; Campagnari, A.A. The K1 capsular polysaccharide from acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect. Immun., 2013, 8(3), 915-922.
32. McConnell, M.J.; Domínguez-Herrera, J.; Smani, Y.; López-Rojas, R.; Docobo-Pérez, F.; Pachón, J. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant acinetobacter baumannii. Infect. Immun., 2011, 79(1), 518-526.
33. McConnell, M.J.; Pachón, J. Active and passive immunization against acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine, 2010, 29(1), 1-5.
34. Kulp, A.; Kuehn, M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol., 2010, 64, 163-184.
35. Kwon, S.O.; Gho, Y.S.; Lee, J.C.; Kim, S.I. Proteome analysis of outer membrane vesicles from a clinical acinetobacter baumannii isolate. FEMS Microbiol. Lett., 2009, 297(2), 150-156.
36. McConnell, M.J.; Rumbo, C.; Bou, G.; Pachón, J. Outer membrane vesicles as an acellular vaccine against acinetobacter baumannii. Vaccine, 2011, 29(34), 5705-5710.
37. Koeberling, O.; Seubert, A.; Granoff, D.M. Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin. J. Infect. Dis., 2008, 198(2), 262-270.
38. Doring, G.; Pier, G.B. Vaccines and immunotherapy against pseudomonas aeruginosa. Vaccine, 2008, 26(8), 1011-1024.
39. Pier, G.B. Pseudomonas aeruginosa surface polysaccharide vaccines. New therapeutic approaches from basic research. Antibiot. Chemother., 1985, 36, 157-167.
40. Harris, G.; Kuo Lee, R.; Lam, C. K.; Kanzaki, G.; Patel, G. B.; Xu, H. H.; Chen, W. A mouse model of acinetobacter baumanniiassociated pneumonia using a clinically isolated hypervirulent strain. Antimicrob. Agents Chemother., 2013, 57(8), 3601-3613